Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
NCT ID: NCT01896193
Description: Safety Analysis Set
Frequency Threshold: 5
Time Frame: Up to 24 weeks plus 30 days
Study: NCT01896193
Study Brief: Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
SOF+RBV 16 Weeks SOF 400 mg tablet once daily + RBV tablets (1000-1200 mg daily based on weight) for 16 weeks None None 1 62 16 62 View
SOF+RBV 24 Weeks SOF 400 mg tablet once daily + RBV tablets (1000-1200 mg daily based on weight) for 24 weeks None None 1 65 21 65 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Version 16.1 View
Foot fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA Version 16.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 16.1 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 16.1 View
Respiratory tract infection viral SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Version 16.1 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 16.1 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA Version 16.1 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Version 16.1 View